# Vibegron: UK patient leaflet, explained

Source: patient information leaflet for Obgemsa 75 mg Film-Coated Tablets (licence PLPI335430434), approved by the MHRA. Leaflet dated 2026-08-21. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/eadb2e75938fe65fb51df4bcea3ae3eebc17a07f

Canonical page: https://pestle.health/uk/vibegron

## What is vibegron for?
Obgemsa is a bladder muscle relaxant that reduces the activity of an overactive bladder. It is used in adults to treat symptoms such as a sudden need to empty the bladder, needing to empty it more often than usual, and not being able to control when to empty it, which leads to wetting yourself.

## Key facts
- The usual dose is 1 tablet per day, with or without food.
- Tell your doctor straight away if you are unable to empty your bladder (urinary retention).
- Do not take it if you are pregnant or think you may be pregnant, and do not breast-feed while taking it.
- Do not stop taking it early or when your symptoms improve, as your symptoms may return. Talk to your doctor before you stop.
- This medicine is subject to additional monitoring, so please report any side effects you get.

## Who should not take vibegron?
- if you are allergic to vibegron or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- if you have trouble emptying your bladder or you have a weak urine stream
- if you are taking any other medicines for overactive bladder syndrome, such as anticholinergic medicines for example oxybutynin, diphenhydramine, solifenacin
- if you have severe liver problems or end-stage kidney disease, as Obgemsa should not be used in these cases
- Do not give to children and adolescents under 18 years, as safety and efficacy have not been established

## Side effects that need urgent help
- Inability to empty your bladder (urinary retention) (uncommon): tell your doctor straight away

## How common are the side effects?
### Common (Up to 1 in 10 people)
- headache
- diarrhoea
- nausea (feeling sick)
- constipation
- urinary tract infection (infection of structures that carry urine)
- residual urine volume increased (an increase in the amount of urine left in the bladder after a voluntary urination)

### Uncommon (Up to 1 in 100 people)
- urinary retention (inability to empty your bladder)
- hot flush
- urinary retention, including urinary straining (inability to empty your bladder)
- rash (including itchy rash, and red rash)

## Other medicines the leaflet mentions
- any other medicines you are taking, have recently taken or might take
- other medicines for overactive bladder, such as anticholinergic medicines (for example oxybutynin, diphenhydramine, solifenacin)
- digoxin (a medicine for heart failure or abnormal heart rhythm)
- dabigatran etexilate (an anticoagulant)
- apixaban (an anticoagulant)
- rivaroxaban (an antithrombotic)

## Pregnancy and breastfeeding
Do not take Obgemsa if you are pregnant, think you may be pregnant or are planning to have a baby, as it is not known how it will affect the baby. It is likely to pass into breast milk and the risks for the baby are unknown, so you should not breast-feed while taking it.

## How to take it
- Take 1 tablet per day, exactly as your doctor has told you.
- Swallow the tablet with a glass of water. If needed, you can crush it and mix it with 1 tablespoon (about 15 mL) of soft food such as applesauce, eat it immediately, then drink a glass of water.
- You may take the tablet with or without food.
- If you miss a dose, take the next dose as normal the next day and do not take a double dose. If you miss several doses, tell your doctor.
- Do not stop taking it early, even if you see no immediate effect, as your bladder may need time to adapt.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
